These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 18237827)

  • 1. Porcine circovirus type 2 (PCV2) vaccination of conventional pigs prevents viremia against PCV2 isolates of different genotypes and geographic origins.
    Fort M; Sibila M; Allepuz A; Mateu E; Roerink F; Segalés J
    Vaccine; 2008 Feb; 26(8):1063-71. PubMed ID: 18237827
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One dose of a porcine circovirus 2 (PCV2) sub-unit vaccine administered to 3-week-old conventional piglets elicits cell-mediated immunity and significantly reduces PCV2 viremia in an experimental model.
    Fort M; Sibila M; Pérez-Martín E; Nofrarías M; Mateu E; Segalés J
    Vaccine; 2009 Jun; 27(30):4031-7. PubMed ID: 19379787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A PCV2 vaccine based on genotype 2b is more effective than a 2a-based vaccine to protect against PCV2b or combined PCV2a/2b viremia in pigs with concurrent PCV2, PRRSV and PPV infection.
    Opriessnig T; O'Neill K; Gerber PF; de Castro AM; Gimenéz-Lirola LG; Beach NM; Zhou L; Meng XJ; Wang C; Halbur PG
    Vaccine; 2013 Jan; 31(3):487-94. PubMed ID: 23174198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An experimental live chimeric porcine circovirus 1-2a vaccine decreases porcine circovirus 2b viremia when administered intramuscularly or orally in a porcine circovirus 2b and porcine reproductive and respiratory syndrome virus dual-challenge model.
    Opriessnig T; Gomes-Neto JC; Hemann M; Shen HG; Beach NM; Huang Y; Halbur PG; Meng XJ
    Microbiol Immunol; 2011 Dec; 55(12):863-73. PubMed ID: 21951266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of pigs against post-weaning multisystemic wasting syndrome by a recombinant adenovirus expressing the capsid protein of porcine circovirus type 2.
    Wang X; Jiang P; Li Y; Jiang W; Dong X
    Vet Microbiol; 2007 Apr; 121(3-4):215-24. PubMed ID: 17215092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The optimized capsid gene of porcine circovirus type 2 expressed in yeast forms virus-like particles and elicits antibody responses in mice fed with recombinant yeast extracts.
    Bucarey SA; Noriega J; Reyes P; Tapia C; Sáenz L; Zuñiga A; Tobar JA
    Vaccine; 2009 Sep; 27(42):5781-90. PubMed ID: 19664739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
    Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
    Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel subunit vaccine co-expressing GM-CSF and PCV2b Cap protein enhances protective immunity against porcine circovirus type 2 in piglets.
    Zhang H; Qian P; Peng B; Shi L; Chen H; Li X
    Vaccine; 2015 May; 33(21):2449-56. PubMed ID: 25863115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of vaccination of boars against porcine circovirus type 2 on ejaculate characteristics, serum antibody titers, viremia, and semen virus shedding.
    Alberti KA; Estienne MJ; Meng XJ
    J Anim Sci; 2011 May; 89(5):1581-7. PubMed ID: 21169515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
    Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
    Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced protective immune response to PCV2 subunit vaccine by co-administration of recombinant porcine IFN-γ in mice.
    Wang YP; Liu D; Guo LJ; Tang QH; Wei YW; Wu HL; Liu JB; Li SB; Huang LP; Liu CM
    Vaccine; 2013 Jan; 31(5):833-8. PubMed ID: 23219694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A candidate inactivated chimeric vaccine PCV1-2 constructed based on PCV1 and PCV2 isolates originating in China and its evaluation in conventional pigs in regard to protective efficacy against PCV2 infection.
    Xujie L; Xiaobo W; Yi S; Jing F; Song G; Xiufan L
    Microbiol Immunol; 2011 Apr; 55(4):254-66. PubMed ID: 21244470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the effectiveness of passive (dam) versus active (piglet) immunization against porcine circovirus type 2 (PCV2) and impact of passively derived PCV2 vaccine-induced immunity on vaccination.
    Opriessnig T; Patterson AR; Madson DM; Pal N; Ramamoorthy S; Meng XJ; Halbur PG
    Vet Microbiol; 2010 May; 142(3-4):177-83. PubMed ID: 19913369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental infection of 3-week-old conventional colostrum-fed pigs with porcine circovirus type 2 and porcine parvovirus.
    Ostanello F; Caprioli A; Di Francesco A; Battilani M; Sala G; Sarli G; Mandrioli L; McNeilly F; Allan GM; Prosperi S
    Vet Microbiol; 2005 Jul; 108(3-4):179-86. PubMed ID: 15916871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
    Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
    J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2.
    Song Y; Jin M; Zhang S; Xu X; Xiao S; Cao S; Chen H
    Vet Microbiol; 2007 Jan; 119(2-4):97-104. PubMed ID: 17005335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of PMWS-associated clinical signs and co-infections by vaccination against PCV2.
    Kixmöller M; Ritzmann M; Eddicks M; Saalmüller A; Elbers K; Fachinger V
    Vaccine; 2008 Jun; 26(27-28):3443-51. PubMed ID: 18513842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunity conferred by an experimental vaccine based on the recombinant PCV2 Cap protein expressed in Trichoplusia ni-larvae.
    Pérez-Martín E; Gómez-Sebastián S; Argilaguet JM; Sibila M; Fort M; Nofrarías M; Kurtz S; Escribano JM; Segalés J; Rodríguez F
    Vaccine; 2010 Mar; 28(11):2340-9. PubMed ID: 20056179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex.
    Fachinger V; Bischoff R; Jedidia SB; Saalmüller A; Elbers K
    Vaccine; 2008 Mar; 26(11):1488-99. PubMed ID: 18304705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
    Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.